Hjem › Precursor T-celle lymfoblastisk leukemi-lymfom › Texas › Houston
Kliniske studier for Precursor T-celle lymfoblastisk leukemi-lymfom i Houston, TX
8 studier for Precursor T-celle lymfoblastisk leukemi-lymfom søker deltakere på steder i og rundt Houston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
RekruttererFase 2
- MD Anderson Cancer Center, Houston
A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
RekruttererFase 2
- MD Anderson Cancer Center, Houston
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
RekruttererFase 1
- MD Anderson Cancer Center, Houston
Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
RekruttererFase 1
- UT MD Anderson, Houston
Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen
RekruttererFase 1
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
RekruttererFase 2
- M D Anderson Cancer Center, Houston
A Registry for People With T-cell Lymphoma
RekruttererObservasjonsstudie
- MD Anderson Cancer Center (Data Collection Only), Houston
Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells
RekruttererFase 1
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Precursor T-celle lymfoblastisk leukemi-lymfom-studier i andre byer
- New York City, NY6 studier
- Columbus, OH5 studier
- Washington, DC4 studier
- Philadelphia, PA4 studier
- Baldwin Park, CA3 studier
- St. Louis, MO3 studier
- Boston, MA3 studier
- Edison, NJ3 studier
- Queens, NY3 studier
- New Rochelle, NY3 studier
- Staten Island, NY3 studier
- East Norwalk, CT3 studier
Andre studier i Houston
- Ikke-småcellet lungekreft145 studier
- Brystkreft126 studier
- Kreft (alle typer)121 studier
- Metastatisk kreft104 studier
- Kolorektal kreft102 studier
- Eggstokkreft89 studier
- Akut myelogen leukemi85 studier
- Lungekreft78 studier
- Prostatakreft76 studier
- Endometriekreft68 studier
- Pankreaskreft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.